Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
International Journal of Pediatrics ; (6): 81-85, 2023.
Artigo em Chinês | WPRIM | ID: wpr-989041

RESUMO

Enuresis(NE)and obstructive sleep apnea(OSA)are common diseases in children, which often cause various social and psychological problems and the coexistence of both seriously affects the physical and mental health of children.At present, there have been many speculations about whether OSA can cause NE and the specific pathogenesis.OSA may be susceptible to NE due to abnormal secretion of humoral factors, sleep-wake disorders, bladder dysfunction, obesity, and psychosomatic factors, among which abnormal secretion of humoral factors and sleep-wake disorders may play a crucial role.In addition, it has been suggested that adenotonsillectomy may be the best treatment option for children suffering from OSA with NE when upper airway obstruction is present.This article summarizes the relationship between NE and OSA and how to treat them, aiming to provide a reference for the clinical treatment of OSA and NE.

2.
Journal of Modern Urology ; (12): 283-286, 2023.
Artigo em Chinês | WPRIM | ID: wpr-1006075

RESUMO

【Objective】 To investigate the possibility of using voiding diary (VD) to predict desmopressin diacetate arginine vasopressin (DDAVP) and enuresis alarm (EA) in the treatment of primary monosymptomatic nocturnal enuresis (PMNE). 【Methods】 A total of 100 children (aged 6 to 14 years) with PMNE treated during Jan.2018 and Oct.2022 were involved. Bladder type was classified with two-week VD. Pseudo-randomization was performed using the Danish REDCap system to group patients into the randomized group and VD group. All patients were treated for 8 weeks. 【Results】 A total of 82 cases met the inclusive criteria. The effective rate was 82.50% (33/40) and 59.52% (25/42) in the VD and randomized groups, respectively, with significant difference (χ2=5.224, P=0.022). In the randomized group, if VD was not considered, the effective rate in the DDAVP and EA subgroups was 81.82% (18/22) and 25.00% (5/20), respectively, with significant difference (χ2=13.625, P=0.000). 【Conclusion】 VD can predict the therapeutic effects of PMNE. It is necessary to record VD for two weeks before selecting appropriate treatment methods. For patients who choose treatment without reference to VD, DDAVP shows better response than EA, but the recurrence rate after discontinuation of treatment requires further follow-up.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA